Senegal vs Wallis and Futuna Islands: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Senegal
0.4%
in 2024
Wallis and Futuna Islands
0.4%
in 2024
Senegal rank
74th
Wallis and Futuna Islands rank
74th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Senegal
- Wallis and Futuna Islands
How they compare
Senegal currently reports 0.4% against 0.4% in Wallis and Futuna Islands, a difference of 0.0%.
Across all 10 years both countries report, Wallis and Futuna Islands has been ahead every year.
Senegal ranks 74th and Wallis and Futuna Islands ranks 74th of 246 countries.
Wallis and Futuna Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Senegal | Wallis and Futuna Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.8% | 1.0% | 0.2% | Wallis and Futuna Islands |
| 2020s | 0.5% | 0.7% | 0.2% | Wallis and Futuna Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Senegal or Wallis and Futuna Islands?
- Senegal, at 0.4% against 0.4% in Wallis and Futuna Islands as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Senegal and Wallis and Futuna Islands?
- 0.0%, with Senegal ahead.
- How many years of comparable data are there for Senegal and Wallis and Futuna Islands?
- 10 years are reported by both, from 2015 to 2024.
- How do Senegal and Wallis and Futuna Islands rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Senegal ranks 74th and Wallis and Futuna Islands ranks 74th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.